Clinical Next- Generation Sequencing (NSG) Testing Market is expected to rise value of USD 356.18 billion by 2026
Global Clinical Next-Generation Sequencing (NSG) Testing Market By Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, Nanopore Sequencing, Other Sequencing Technologies), Application (Diagnostics, Drug Discovery, Agricultural & Animal Research, Other Applications), End- User (Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Other End Users), Service (Human Genome Sequencing, Single Cell Sequencing, Microbial Genome-based Sequencing, Gene Regulation Services, Animal & Plant Sequencing, Other Sequencing Services), Workflow (Pre-sequencing, Sequencing, Data Analysis), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026 For an ever increasing business growth and maximum return on investment (ROI), Clinical Next-Generation Sequencing (NSG) Testing Market rese...